Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary pulmonary lymphoma.

J Cadranel1, M Wislez, M Antoine

  • 1Dept of Pneumology and Respiratory Intensive Care, Tenon Hospital, Paris, France. jacques.cadranel@tnn.ap-hop-paris.fr

The European Respiratory Journal
|October 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 "DICIPLE" Phase III Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

AFSOS-SFRO Guidelines on Radiation-Induced Lung Injury.

Clinical lung cancer·2025
Same author

Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Home enteral nutrition does not decrease oral feeding in children during the first year of nutritional support.

Clinical nutrition (Edinburgh, Scotland)·2024
Same author

[Severe hemoptysis in the onco-hematology patient].

Revue des maladies respiratoires·2023
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
Same journal

ERS Statement on ultrasound guided interventions in respiratory disease.

The European respiratory journal·2026
Same journal

When symptoms and resting tests disagree in interstitial lung disease: a selective role for cardiopulmonary exercise testing.

The European respiratory journal·2026
Same journal

Clinical Practice Guideline for the diagnosis of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency Disorders (CVID) - an ERS Clinical Research Collaboration.

The European respiratory journal·2026
Same journal

SARS-CoV-2 (E)-protein induces rapid TLR2-mediated T cell activation in mouse lungs revealed by intravital lung microscopy.

The European respiratory journal·2026
Same journal

Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertension.

The European respiratory journal·2026
See all related articles

Primary pulmonary clonal lymphoid proliferations include low-grade and high-grade B-cell lymphomas, and lymphomatoid granulomatosis. Each has distinct characteristics, prognoses, and treatment considerations.

Area of Science:

  • Pulmonary Medicine
  • Hematology
  • Oncology

Background:

  • Primary pulmonary clonal lymphoid proliferation encompasses three distinct entities.
  • These conditions involve lymphoid tissue within the lungs, with varying origins and behaviors.

Purpose of the Study:

  • To review the pathophysiology, diagnosis, prognosis, and treatment of primary pulmonary clonal lymphoid proliferations.
  • To differentiate between low-grade pulmonary B-cell lymphoma, high-grade pulmonary B-cell lymphoma, and lymphomatoid granulomatosis.

Main Methods:

  • Literature review and synthesis of existing data on primary pulmonary lymphoid proliferations.
  • Analysis of pathophysiological, diagnostic, prognostic, and therapeutic aspects.

Main Results:

Related Experiment Videos

  • Low-grade pulmonary B-cell lymphoma, arising from mucosa-associated lymphoid tissue, is common, indolent, and has an excellent prognosis, though treatment remains debated.
  • High-grade pulmonary B-cell lymphoma is rare, associated with immunodeficiency, has a poor prognosis, and requires treatment tailored to the underlying condition.
  • Lymphomatoid granulomatosis inclusion is controversial due to rare clonal demonstration and frequent extrapulmonary involvement, with highly variable prognoses.

Conclusions:

  • Primary pulmonary clonal lymphoid proliferations present unique challenges in diagnosis and management.
  • Tailored therapeutic strategies are essential, considering the specific entity and patient's overall health.
  • Further research is needed to clarify the role and optimal treatment for lymphomatoid granulomatosis within this classification.